Two research and development buildings, eight- and 10-stories each, aim to be the gateway of South San Francisco’s biotech hub on the east side of Highway 101.

Ensuring the project is connected to the community, aligns with the city’s general plan and isn’t affected by the simultaneous construction site at 121 E. Grand Ave. nearby were some of the concerns discussed during a South San Francisco Planning Commission meeting for the development at 100 E. Grand Ave. and Sylvester Road, the current site of a warehouse. A 17-story tower with lab, office and retail space is planned for 121 E. Grand Ave., current site of Comfort Inn and east of the train station.

Recommended for you

(650)344-5200, ext. 105

Recommended for you

(0) comments

Welcome to the discussion.

Keep the discussion civilized. Absolutely NO personal attacks or insults directed toward writers, nor others who make comments.
Keep it clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't threaten. Threats of harming another person will not be tolerated.
Be truthful. Don't knowingly lie about anyone or anything.
Be proactive. Use the 'Report' link on each comment to let us know of abusive posts.
PLEASE TURN OFF YOUR CAPS LOCK.
Anyone violating these rules will be issued a warning. After the warning, comment privileges can be revoked.

Thank you for visiting the Daily Journal.

Please purchase a Premium Subscription to continue reading. To continue, please log in, or sign up for a new account.

We offer one free story view per month. If you register for an account, you will get two additional story views. After those three total views, we ask that you support us with a subscription.

A subscription to our digital content is so much more than just access to our valuable content. It means you’re helping to support a local community institution that has, from its very start, supported the betterment of our society. Thank you very much!

Want to join the discussion?

Only subscribers can view and post comments on articles.

Already a subscriber? Login Here